The Avita Medical (ASX:AVH) share price just leapt 16% because of this

The company's CEO commented today's news could spell the future of Avita's technology.

| More on:
Lab worker puts hands in the air and dances around.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today was a great day on the ASX for the Avita Medical Inc (ASX: AVH) share price.

The medical technology company's stock was boosted by news that the US authority Centers for Medicare and Medicaid Services has approved Avita's application for a new device category code.

The new code means the cost of Avita's RECELL System will be able to be offset when it's used in hospitals and surgical centres.

Avita's RECELL System is a skin restorative system that allows healthcare professionals to restore skin cells to burned areas.

As of Thursday's close, the Avita share price is $15.13, 15.8% higher than it was at Wednesday's close.

Let's take a closer look at today's news from Avita.

The latest news of the RECELL System

The Avita share price surged higher today as the company's CEO noted the new code could see its RECELL System adopted widely.

According to the company's release, the code under which the RECELL System will soon lie is designed to help facilities adopt new technology by offsetting the cost. The system will adopt the new code on 1 January 2022.

Avita's CEO Mike Perry commented on the news that drove the company's share price, saying:

The new code will enable health care providers to treat burn patients with RECELL in various care settings especially during the pandemic, and over the long run, help foster adoption of RECELL in small burns as well as in future indications.

Perry noted the new code "lays the reimbursement foundation for the soft tissue repair indication". He also said the space represents a $450 million serviceable market.

Previous studies have found that the RECELL System resulted in 97.5% less donor skin being needed to treat second degree burns. Other findings from the studies have also highlighted that the RECELL System means there is 32% less donor skin required to treat patients with third degree burns.

Avita share price snapshot

Today's gain has boosted the Avita share price back into the ASX green.

It is now 1.3% higher than it was at the start of 2021. However, it's still 14.9% lower than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Avita Medical Limited. The Motley Fool Australia has recommended Avita Medical Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A red heart-shaped balloon floats up above the plain white ones, indicating the best shares.
Healthcare Shares

Heart tech firm's shares surge after huge capital raise

A strategic investor has also jumped on board.

Read more »

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »